Advertisement

Family History of Alcoholism Influences Naltrexone-Induced Reduction in Alcohol Drinking

      Background

      The purpose of this study was to examine the interactive effects of family history of alcoholism (FH+, FH−) and naltrexone dose (0, 50, 100 mg/day) on alcohol drinking.

      Methods

      Ninety-two, non–treatment-seeking alcohol-dependent participants received naltrexone daily for 6 days. On the 6th day, they participated in a laboratory paradigm involving exposure to a priming dose of alcohol followed by a 2-hour drinking period in which they made choices between consuming alcoholic drinks and receiving money.

      Results

      Total number of drinks consumed during the drinking period was significantly decreased by the 100-mg dose of naltrexone in FH+ drinkers. Secondary analyses in male drinkers (n = 70) indicated that 100 mg of naltrexone significantly decreased drinking in FH+ participants and increased drinking in FH− drinkers.

      Conclusions

      These results suggest that family history of alcoholism might be a significant clinical predictor of response to naltrexone and that FH+ men are more likely to benefit from naltrexone therapy for alcohol drinking.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Anton R.F.
        • Drobes D.J.
        • Voronin K.
        • Durazo-Azizv R.
        • Moak D.
        Naltrexone effects on alcohol consumption in a clinical lab paradigm: Temporal effects of drinking.
        Psychopharmacol. 2004; 173: 32-40
        • Anton R.F.
        • O’Malley S.S.
        • Ciraulo D.A.
        • Cisler R.A.
        • Couper D.
        • Donovan D.M.
        • et al.
        Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial.
        JAMA. 2006; 295: 2003-2017
        • Conway K.P.
        • Swendsen J.D.
        • Merinkangas K.R.
        Alcohol expectancies, alcohol consumption and problem drinking: The moderating role of family history.
        Addict Behav. 2003; 28: 823-836
        • Drobes D.J.
        • Anton R.F.
        • Thomas S.E.
        • Voronin K.
        A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: Naltrexone and nalmefene.
        Neuropsychopharmacol. 2003; 28: 755-764
        • First M.B.
        • Spitzer R.L.
        • Gibbon M.
        • Williams J.B.W.
        Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient Edition.
        Biometrics Research, New York State Psychiatric Institute, New York1996
        • Garbutt J.C.
        • Kranzler H.R.
        • O’Malley S.S.
        • Gastfriend D.R.
        • Pettinati H.M.
        • Silverman B.L.
        • et al.
        Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: A randomized controlled trial.
        JAMA. 2005; 293: 1617-1625
        • Gueorguieva R.
        • Wu R.
        • Pittman B.
        • O’Malley S.
        • Krystal J.H.
        New insights into the efficacy of naltrexone for alcohol dependence from the trajectory-based analyses.
        Biol Psychiatry. 2006; ([Epub ahead of print])
        • Kiefer F.
        • Helwig H.
        • Tarnaske T.
        • Otte C.
        • Jahn H.
        • Wiedemann K.
        Pharmacological relapse prevention of alcoholism: Clinical predictors of outcome.
        Eur Addict Res. 2005; 11: 83-91
        • King A.C.
        • Volpicelli J.R.
        • Frazer A.
        • O’Brien C.P.
        Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence.
        Psychopharmacol. 1997; 129: 15-22
        • Merinkangas K.R.
        • Stolar M.
        • Stevens D.E.
        • Goulet J.
        • Preisig M.
        • Fenton B.
        • et al.
        Familial transmission of substance use disorders.
        Arch Gen Psychiatry. 1998; 55: 973-979
        • Mitchell J.M.
        • Liang M.T.
        • Fields H.L.
        A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats.
        Psychopharmacol. 2005; 182: 384-392
        • Monterosso J.R.
        • Flannery B.A.
        • Pettinati H.M.
        • Oslin D.W.
        • Rukstalis M.
        • O’Brien C.P.
        • Volpicelli J.R.
        Predicting treatment response to naltrexone: the influence of craving and family history.
        Am J Addictions. 2001; 10: 258-268
      1. National Advisory Council on Alcohol Abuse and Alcoholism (1989, 2005): Recommended Council Guidelines on Ethyl Alcohol Administration in Human Experimentation, Revised May 2005. Available at: http://www.niaaa.nih.gov/Resources/ResearchResources/job22.htm.

        • O’Malley S.S.
        • Jaffe A.J.
        • Chang G.
        • Schottenfeld R.S.
        • Meyer R.E.
        • Rounsaville B.
        Naltrexone and coping skills therapy for alcohol dependence.
        Arch Gen Psychiatry. 1992; 49: 881-887
        • O’Malley S.S.
        • Krishnan-Sarin S.
        • Farren C.
        • Sinha R.
        • Kreek J.
        Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo–pituitary–adrenocortical axis.
        Psychopharmacol. 2002; 160: 19-29
        • Oslin D.W.
        • Berrettini W.
        • Kranzler H.R.
        • Pettinati H.
        • Gelernter J.
        • Volpicelli J.R.
        • et al.
        A functional polymorphism of the Mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.
        Neuropsychopharmacol. 2003; 28: 1546-1552
        • Oswald L.M.
        • Wand G.S.
        Opioids and alcoholism.
        Physiol Behav. 2004; 81: 339-358
        • Ponce G.
        • Sanchez-Garcia J.
        • Rubio G.
        • Rodriguez-Jimenez R.
        • Jimenez-Arriero M.A.
        • Palomo T.
        Efficacy of naltrexone in the treatment of alcohol dependence disorder in women.
        Actas Esp Psiquiatr. 2005; 33: 13-18
        • Rice J.P.
        • Reich T.
        • Bucholz K.K.
        • Neuman R.J.
        • Fishman R.
        • Rochberg N.
        • et al.
        Comparison of direct interview and family history of diagnoses of alcohol dependence.
        Alcohol Clin Exp Res. 1995; 19: 1018-1023
        • Rubio G.
        • Ponce G.
        • Rodriguez-Jimenez R.
        • Jimenez-Arriero M.A.
        • Hoenicka J.
        • Paloma T.
        Clinical predictors of response to naltrexone in alcohol patients: Who benefits most from treatment with naltrexone?.
        Alcohol Alcohol. 2005; 40: 227-233
        • Sinha R.
        • Krishnan-Sarin S.
        • Farren C.
        • O’Malley S.S.
        Naturalistic follow-up of drinking behavior following participation in an alcohol administration study.
        J Subst Abuse Treat. 1999; 17: 159-162
        • Sobell L.C.
        • Sobell M.B.
        Timeline follow-back: A technique for assessing self-reported ethanol consumption.
        in: Allen J. Litten R.Z. Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. Human Press, Totowa, New Jersey1992: 41-72
        • Srisurapanont M.
        • Jarusuraisin N.
        Opioid antagonists for alcohol dependence.
        Cochrane Database Syst Rev. 2002; : CD001867
        • Swift R.M.
        • Whelihan W.
        • Kuznetsov O.
        • Burongiorno G.
        • Hsuing H.
        Naltrexone induced alterations in human ethanol intoxication.
        Am J Psychiatry. 1994; 151: 1462-1467
        • Uhart M.
        • Oswald L.
        • McCaul M.E.
        • Chong R.
        • Wand G.S.
        Hormonal responses to psychological stress and family history of alcoholism.
        Neuropsychopharmacol. 2006; 31: 2255-2263
        • Vanvoorst W.A.
        • Quirk S.W.
        Are relations between paternal history of alcohol problems and changes in drinking moderated by positive expectancies?.
        Alcohol Clin Exp Res. 2003; 27: 25-30
        • Volpicelli J.R.
        • Alterman A.I.
        • Hayashida M.
        • O’Brien C.P.
        Naltrexone in the treatment of alcohol dependence.
        Arch Gen Psychiatry. 1992; 49: 876-880